Iridex (IRIX) delivered earnings and revenue surprises of 29.41% and -5.14%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Iridex Withdraws Its FY20 Guidance

08:26pm, Monday, 11'th May 2020
MOUNTAIN VIEW, Calif., May 11, 2020 -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended March 28, 2020. Commenting on the.
May 03, 2020 (The Expresswire) -- The key purpose of this “Indirect Ophthalmoscope Market” Size report 2020 is to deliver a definite and strategic analysis...
MOUNTAIN VIEW, Calif., April 28, 2020 -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the first quarter of 2020 after the.
IRIDEX Corporation (IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the appointment of Doris Engibous to its
Global Medical Laser Systems Market is anticipated to reach USD 12.5 billion by 2022. Medical lasers are mainly used for the treatment and diagnosis of medical circumstances and are subject to photoch
New York, April 15, 2020 -- Reportlinker.com announces the release of the report "Cold Laser Therapy Market Research Report by Product, by Application, by End User - Global.
Cold Laser Therapy Market Research Report by Product (Diode Laser System, Dye Lasers System, Gas Laser System, and Solid-State Laser System), by Application (Dentistry, Dermatology, Laser Acupuncture,
New York, April 14, 2020 -- Reportlinker.com announces the release of the report "Cold Laser Therapy Market Research Report by Product, by Application, by End User - Global.
Apr 09, 2020 (The Expresswire) -- Global "Glaucoma Surgery Market" 2020 Global Industry Research Report is deep analysis by historical and current status of...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE